Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1785 |
Palbociclib
PD 0332991,帕博西尼,帕布昔利布 |
CDK | Cell Cycle/Checkpoint |
Palbociclib (PD 0332991) 是一种 CDK 抑制剂,抑制 CDK4 和 CDK6 (IC50=11/16 nM),具有口服活性。Palbociclib 具有抗肿瘤活性,有用于 ER 阳性和 HER2 阴性乳腺癌的研究潜力。 | |||
T6239 |
Palbociclib monohydrochloride
PD 0332991 hydrochloride,Palbociclib hydrochloride,帕布昔利布盐酸盐,Palbociclib (PD-0332991) HCl |
CDK | Cell Cycle/Checkpoint |
Palbociclib monohydrochloride (PD 0332991 hydrochloride) 是一种口服的细胞周期蛋白依赖性激酶 (CDK) 抑制剂,具有潜在的抗肿瘤活性。它抑制 CDK4和 CDK6,IC50分别为11 nM,16 nM。它有用于 ER 阳性和 HER2 阴性乳腺癌的研究潜力。 | |||
T6240 |
Palbociclib Isethionate
Palbociclib (PD0332991) Isethionate,帕博西尼羟乙基磺酸盐,PD 0332991 isethionate,帕布昔利布羟乙基磺酸盐 |
CDK | Cell Cycle/Checkpoint |
Palbociclib Isethionate (PD 0332991 isethionate) 是一种高选择性的CDK4/6抑制剂,IC50为11 nM 和16 nM。它对一组 36 种额外的蛋白激酶没有抑制作用。 | |||
T28291 |
Palbociclib-Succinic acid
Palbociclib-hemi Succinic acid,Palbociclib-Succinate, |
||
Palbociclib-Succinic acid is a Palbociclib- derivative with a succinic acid linker. The carboxy group of Palbociclib-Succinic acid can be used to conjugate with other molecules such as peptides, proteins, or polymers. Palbociclib-Succinic acid is a useful | |||
T33865 |
Palbociclib-SMCC
PD0332991-SMCC,Palbociclib-SMCC linker,PD 0332991-SMCC,PD-0332991-SMCC |
||
Palbociclib-SMCC is a Palbociclib derivative with a SMCC linker. | |||
T12355 |
Palbociclib-d8
PD 0332991 D8,Palbociclib D8 |
CDK | Cell Cycle/Checkpoint |
Palbociclib D8 is a deuterium labeled Palbociclib. Palbociclib is a selective and orally active inhibitor of CDK4 and CDK6 (IC50s of 11 and 16 nM, respectively). | |||
T18515 |
Palbociclib-propargyl
PROTAC CDK6 ligand 1 |
Others | Others |
Palbociclib-propargyl, a PROTAC ligand targeting the protein CDK6, connects to the CRBN ligand through a PEG linker to form PROTAC CP-10. CP-10 exhibits a potent DC50 value of 2.1 nM against CDK6[1]. | |||
T63634 | Palbociclib dihydrochloride | ||
Palbociclib (PD 0332991) dihydrochloride 是口服具有活力的、选择性的 CDK4 (IC50: 11 nM) 和 CDK6 (IC50: 16 nM) 抑制剂。Palbociclib dihydrochloride 对癌细胞具有抗增殖活性,并阻滞细胞周期,能够用于 HR 阳性和 HER2 阴性乳腺癌,以及肝细胞癌的相关研究。 | |||
T72507 |
Palbociclib orotate
PD 0332991 orotate |
CDK | Cell Cycle/Checkpoint |
Palbociclib (PD 0332991) orotate 是一种口服活性的CDK4和CDK6选择性抑制剂,其IC50值分别为11 nM和16 nM。该化合物对癌细胞展示出抗增殖效果,并促使细胞周期处于阻滞状态。该药物适用于HR阳性、HER2阴性乳腺癌以及肝细胞癌的研究。 | |||
T63576 | Palbociclib hydrochloride | ||
Palbociclib (PD 0332991) hydrochloride 是一种选择性的、有效的 CDK4 (IC50: 11 nM) 和 CDK6 (IC50: 16 nM)抑制剂。Palbociclib hydrochloride 对癌细胞具有抗增殖作用,并诱导细胞周期阻滞,能够用于 HR 阳性和 HER2 阴性乳腺癌,以及肝细胞癌的相关研究。 | |||
T64486 | 6-Desacetyl Palbociclib | ||
6-Desacetyl Palbociclib 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T64486。 | |||
T78130 |
N-Methyl Palbociclib
|
Drug Metabolite | Metabolism |
N-MethylPalbociclib是一种Palbociclib的杂质。Palbociclib(PD 0332991)是一种口服活性的CDK4和CDK6抑制剂。 | |||
T20656 |
Verapamil
NSC 135784,维拉帕米,NSC-135784,CP-16533-1,(±)-Verapamil |
P450; Calcium Channel; P-gp | Membrane transporter/Ion channel; Metabolism; Neuroscience |
Verapamil (CP-16533-1) 是一种钙通道阻滞剂,是一种口服有效的 P-gp 抑制剂。Verapamil 抑制 CYP3A4,可用于治疗高血压、心律失常和心绞痛的研究。 | |||
T1010 |
Verapamil hydrochloride
Manidon,盐酸维拉帕米,(±)-Verapamil hydrochlorid,Verapamil HCl,Calcan hydrochloride |
P450; Calcium Channel; P-gp | Membrane transporter/Ion channel; Metabolism; Neuroscience |
Verapamil hydrochloride (Verapamil HCl) 是一种钙通道阻滞剂,是一种可口服的 P 糖蛋白 (P-gp) 抑制剂,可抑制CYP3A4,用于高血压、心律不齐和心绞痛的研究。 | |||
T60098 |
MSC2504877
3-(4-(2-Hydroxypropan-2-yl)phenyl)-6-methylpyrrolo[1,2-a]pyrazin-1(2H)-one |
Others | Others |
MSC2504877 是一种tankyrase 抑制剂,可增强临床CDK4/6 抑制剂的作用。 MSC2504877 抑制由 palbociclib 引起的 Cyclin D2 和 Cyclin E2 的上调,并增强对 phospho-Rb 的抑制。 | |||
T77923 |
BSJ-03-204 triTFA
|
CDK | Cell Cycle/Checkpoint |
BSJ-03-204 triTFA是一种融合了Cereblon配体和CDK配体的PROTAC,作为基于Palbociclib的、高效的CDK4/6双重降解剂,选择性地对CDK4/D1和CDK6/D1表现出26.9 nM和10.4 nM的IC50值。它不会引发IKZF1/3的降解,展现了潜在的抗癌活性。 |